Introduction: Navigating the Competitive Landscape of Neurovascular Devices
The neuro-vascular devices market is experiencing a period of unprecedented competition, resulting from the rapid diffusion of new devices, the regulatory framework, and the growing demand for minimally invasive solutions. Several players, such as the original equipment manufacturers, the IT service companies, and the new artificial intelligence companies, are competing for leadership, using advanced data analytics, automation, and IoT. The original equipment manufacturers are concentrating on improving the performance and safety of their products, while the IT service companies are developing integrated solutions to improve the efficiency of the clinical work-flow and the quality of patient care. The new artificial intelligence companies are launching biometric and green initiatives to reshape the traditional clinical models. Looking to 2024–2025, significant regional opportunities are expected, especially in Asia-Pacific and North America, where the strategic deployment of cutting-edge technology will be key to capturing market share and meeting the changing needs of clinicians and patients.
Competitive Positioning
Full-Suite Integrators
These vendors offer a comprehensive solution for all neuro- and vascular device segments and ensure a unified approach to patient care.
Vendor | Competitive Edge | Solution Focus | Regional Focus |
Medtronic |
Extensive product portfolio and innovation |
Neurovascular therapies and devices |
Global |
Abbott Laboratories |
Strong R&D and market presence |
Neurovascular intervention solutions |
North America, Europe |
Boston Scientific |
Diverse product offerings and technology |
Interventional neurovascular devices |
Global |
Stryker |
Innovative surgical solutions and technologies |
Neurovascular intervention products |
North America, Europe |
Specialized Technology Vendors
These companies focus on niche products and applications, with innovations tailored to specific neuro- and angiographic applications.
Vendor | Competitive Edge | Solution Focus | Regional Focus |
MicroVention |
Advanced embolization and stenting technologies |
Endovascular neurovascular devices |
Global |
Penumbra |
Cutting-edge thrombectomy devices |
Neurovascular thrombectomy solutions |
North America, Europe |
Neuronetics |
Innovative neuromodulation therapies |
Neurovascular treatment technologies |
North America |
Cerenovus |
Focused on stroke intervention solutions |
Neurovascular devices for stroke care |
Global |
Infrastructure & Equipment Providers
Vendors of neuro- and angiographic equipment and accessories are essential to neuro- and angiographic procedures and interventions.
Vendor | Competitive Edge | Solution Focus | Regional Focus |
Asahi Intecc |
High-quality guidewires and catheters |
Interventional access devices |
Asia, North America |
Terumo |
Comprehensive vascular access solutions |
Neurovascular access devices |
Global |
iVascular |
Innovative vascular solutions and devices |
Interventional vascular products |
Europe, Asia |
Acandis |
Focus on innovative neurovascular solutions |
Neurovascular intervention devices |
Europe |
Sahajanand Medical Technologies |
Cost-effective vascular solutions |
Interventional cardiology and neurovascular |
Asia, Europe |
Neuravi |
Specialized in neurovascular thrombectomy |
Thrombectomy devices |
Europe, North America |
Johnson and Johnson |
Strong brand and extensive distribution |
Medical devices across various segments |
Global |
Emerging Players & Regional Champions
- NeuroVasc (USA): Thrombectomy devices and neuro-stents. Recently signed a contract with a large hospital network for clinical trials. Challenges established suppliers with less expensive, but more advanced technology.
- Cerebrotech Medical Systems (USA) - Non-invasive monitoring of brain pressure. The company has recently implemented its technology in several leading neurology departments, complementing existing solutions with real-time data analysis.
- Stryker (Europe): Neurovascular products such as coils and stent-retrievers. Has recently expanded its market presence in Eastern Europe by entering into strategic alliances, thereby gaining an advantage over the local players.
- Medtronic (Asia-Pacific): has introduced a new range of flow diversion devices for the Asian market. It has also signed a distribution agreement with a major regional health care provider, thus establishing itself as a major player in a rapidly growing market.
Regional Trends: By 2023, the neurovascular device market will have a significant growth in Asia-Pacific due to rising investments in the health care industry and an increasing aging population. The trend of technology specialization will be toward minimally invasive procedures and real-time monitoring solutions. New entrants will focus on cost-effective innovations to challenge established players.
Collaborations & M&A Movements
- The Stryker Company and Medtronic teamed up to develop next-generation stents for the treatment of strokes.
- Vascular Dynamics was a neuro-vascular company, whose assets were acquired by Penumbra, Inc., to broaden its product line and strengthen its position in the neuro-vascular field.
- Boston Scientific and Microvention announced a collaboration to develop and commercialize embolization devices, in order to capture a larger share of the growing neuro-vascular market.
Competitive Summary Table
Capability | Leading Players | Remarks |
Endovascular Coiling |
Medtronic, Stryker |
Pipeline Flex is characterized by its flexibility and deliverability, which makes it an ideal instrument for successful operations. Stryker's Neuroform Atlas provides advanced delivery systems that facilitate access to difficult anatomies, as shown by recent clinical studies indicating reduced complication rates. |
Stent-Assisted Coiling |
Boston Scientific, Terumo |
The Solitaire stent made by Boston Scientific is well-suited to difficult cases, and is widely used. Terumo’s FRED stent is known for its unique design, which minimizes trauma to the artery. It has received excellent results in recent clinical trials. |
Flow Diversion |
Cerenovus, Medtronic |
Pipeline, the Cerenovus device, is a leader in the field of blood diversion. It has an extensive clinical record of its effectiveness in the treatment of large aneurysms. The Pipeline device has shown promising results in reducing the recurrence rate of aneurysms and is the preferred choice of neurosurgeons. |
Neurovascular Imaging |
Siemens Healthineers, GE Healthcare |
With its Artis Pheno system, Siemens has combined advanced diagnostics with real-time guidance to enhance the accuracy of its surgical procedures. GE’s Revolution CT has played a major role in advancing diagnostics, as recent studies have demonstrated. |
Robotic-Assisted Surgery |
Intuitive Surgical, Medtronic |
The da Vinci system has become the leading robot for neurovascular surgery, with numerous case studies showing that it improves precision and recovery times. Medtronic’s Hugo system is gaining in popularity because of its versatility and its integration with AI to enhance surgical outcomes. |
Conclusion: Navigating Neurovascular Market Dynamics
The neuro- and vascular device market will be highly competitive in 2023 and is expected to be fragmented. Regional trends show a strong demand in Asia-Pacific and North America, which should lead to the development of appropriate strategies. The main competitors are large companies with their brand and distribution network, while new entrants focus on innovation and niche products. The key to market leadership will be the integration of AI in products, automation of manufacturing processes, sustainable initiatives and the flexibility of business processes. These are the capabilities that will help companies maintain their competitiveness and adapt to the changing needs of the market.
Report Attribute/Metric |
Details |
Base Year For Estimation |
2021 Forecast Period 2022-2030 Historical Data 2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Product, Therapeutic Application, End User Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors Stryker, Medtronic, Johnson & Johnson Services Inc., TERUMO CORPORATION, Abbott, Merit Medical Systems Inc., Medikit Co. Ltd., Penumbra Inc., MicroPort Scientific Corporation, Evasc, Rapid Medical, Neuravi, L. Gore & Associates Inc., OxfordEndovascular, Sensome, Blockade Medical LLC., Delaware Corporation, Secant Group LLC, Gynesonics Key Market Opportunities Massive Demand for Minimally Invasive Procedures to Present Opportunities Key Market Drivers Expanding Patient Pool Fosters Demand for Neurovascular Devices |
Historical Data |
2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Product, Therapeutic Application, End User Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors Stryker, Medtronic, Johnson & Johnson Services Inc., TERUMO CORPORATION, Abbott, Merit Medical Systems Inc., Medikit Co. Ltd., Penumbra Inc., MicroPort Scientific Corporation, Evasc, Rapid Medical, Neuravi, L. Gore & Associates Inc., OxfordEndovascular, Sensome, Blockade Medical LLC., Delaware Corporation, Secant Group LLC, Gynesonics Key Market Opportunities Massive Demand for Minimally Invasive Procedures to Present Opportunities Key Market Drivers Expanding Patient Pool Fosters Demand for Neurovascular Devices |
Forecast Period |
2022-2030 Historical Data 2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Product, Therapeutic Application, End User Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors Stryker, Medtronic, Johnson & Johnson Services Inc., TERUMO CORPORATION, Abbott, Merit Medical Systems Inc., Medikit Co. Ltd., Penumbra Inc., MicroPort Scientific Corporation, Evasc, Rapid Medical, Neuravi, L. Gore & Associates Inc., OxfordEndovascular, Sensome, Blockade Medical LLC., Delaware Corporation, Secant Group LLC, Gynesonics Key Market Opportunities Massive Demand for Minimally Invasive Procedures to Present Opportunities Key Market Drivers Expanding Patient Pool Fosters Demand for Neurovascular Devices |
Growth Rate |
5.7% (2022-2030 Base Year 2021 Forecast Period 2022-2030 Historical Data 2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Product, Therapeutic Application, End User Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors Stryker, Medtronic, Johnson & Johnson Services Inc., TERUMO CORPORATION, Abbott, Merit Medical Systems Inc., Medikit Co. Ltd., Penumbra Inc., MicroPort Scientific Corporation, Evasc, Rapid Medical, Neuravi, L. Gore & Associates Inc., OxfordEndovascular, Sensome, Blockade Medical LLC., Delaware Corporation, Secant Group LLC, Gynesonics Key Market Opportunities Massive Demand for Minimally Invasive Procedures to Present Opportunities Key Market Drivers Expanding Patient Pool Fosters Demand for Neurovascular Devices |